Location History:
- Lafayette Hills, PA (US) (1983 - 1984)
- Lafayette Hill, PA (US) (1976 - 1989)
Company Filing History:
Years Active: 1976-1989
Title: The Innovations of Harvey Schwam
Introduction
Harvey Schwam is a notable inventor based in Lafayette Hill, PA (US). He has made significant contributions to the field of ophthalmology, particularly in the development of antiglaucoma agents. With a total of 4 patents to his name, Schwam's work has had a meaningful impact on the treatment of elevated intraocular pressure and glaucoma.
Latest Patents
Among his latest patents, Schwam has developed thiophene sulfonamide antiglaucoma agents. These agents, specifically aryl (or aralkyl)-sulfonylthiophene-2-sulfonamides containing a basic functional group, are efficacious in treating elevated intraocular pressure and glaucoma following topical ocular administration. Another significant patent is for 5-hydroxy-2-benzothiazolesulfonamide, which is useful for the topical treatment of elevated intraocular pressure. This patent also includes ophthalmic compositions such as drops and inserts.
Career Highlights
Harvey Schwam is currently associated with Merck & Company, Inc., a leading pharmaceutical company. His work at Merck has allowed him to focus on innovative solutions for eye care, contributing to advancements in the treatment of glaucoma.
Collaborations
Throughout his career, Schwam has collaborated with esteemed colleagues, including Otto W. Woltersdorf, Jr. and Stuart R. Michelson. These collaborations have further enriched his research and development efforts in the field of ophthalmology.
Conclusion
Harvey Schwam's contributions to ophthalmology through his patents and work at Merck & Company, Inc. highlight his dedication to improving eye care. His innovative solutions continue to pave the way for advancements in the treatment of glaucoma and elevated intraocular pressure.